Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
31.73
-0.63 (-1.95%)
At close: Nov 7, 2025, 4:00 PM EST
32.00
+0.27 (0.85%)
After-hours: Nov 7, 2025, 4:47 PM EST

AAPG Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for AAPG stock has a target of 48, which predicts a 51.28% increase from the current stock price of 31.73.

Price Target: $48 (+51.28%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$48$48$48$48
Change+51.28%+51.28%+51.28%+51.28%

Analyst Ratings

The average analyst rating for AAPG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingSep '25Oct '25Nov '25
Strong Buy000
Buy112
Hold000
Sell000
Strong Sell000
Total112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Initiates
$48
BuyInitiates$48+51.28%Nov 5, 2025
JP Morgan
JP Morgan
Buy
Initiates
n/a
BuyInitiatesn/an/aMar 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
598.12M
from 980.65M
Decreased by -39.01%
Revenue Next Year
2.80B
from 598.12M
Increased by 368.64%
EPS This Year
-3.14
from -1.34
EPS Next Year
2.37
from -3.14
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
12.45M27.91M209.71M221.98M980.65M598.12M2.80B
Revenue Growth
-14.22%124.18%651.38%5.85%341.77%-39.01%368.64%
EPS
-3.14-3.07-3.35-3.28-1.34-3.142.37
EPS Growth
-------
Forward PE
------95.30
No. Analysts
-----1010
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High766.5M3.4B
Avg598.1M2.8B
Low499.2M1.8B

Revenue Growth

Revenue Growth20252026202720282029
High
-21.8%
473.3%
Avg
-39.0%
368.6%
Low
-49.1%
198.9%

EPS Forecast

EPS202520262027
High-2.474.84
Avg-3.142.37
Low-3.68-0.80

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.